Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

I don't think the market is viewing $2.5 million as significant enough to warrant serious new buying of NAVB shares. If a fund had thrown somewhere between $20 million and $100 million into Macrophage Theraputics for ownership of the subsidiary between 4% and 20% respectively (or even more), that would be far more significant. As it is, $2.5 million for .5% ownership of MT is just that - a measly $2.5 million. MT is worth the $2.5 million...not a cent more until additional investments are made or the market seems NAVB shares worth buying because Navidea owns MT. The Oldtimers seem to be in love with this capital raise as if it is sure fire proof that MT will be worth billions, and quickly. I like their optimism, but I don't share it presently.

We have a long way to go before this thing moves. And for all we know, the $2.5 million is just Crede deal money that hasn't been wasted yet on hiring more new Lymphoseek sales representatives. The initial capital to MT of $2.5 million is simply insignificant. Can this stock close above 2.00 ever again?

I'm getting mighty impatient over here...again!